$WEYS

WEYS: Earnings and sales fell amid tariff-driven margin pressure, with Florsheim outperforming peers

Weyco Group (WEYS) reported a decline in net sales and earnings year-over-year. This downturn was attributed to lower demand and significant tariff impacts, which compressed gross margins. While most major brands saw sales drops, Florsheim was an exception, showing resilience.

Original reporting
Published Mar 4, 2026, 8:52 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 4, 2026, 9:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$WEYS
Bearish
medium confidence
Mentioned
$WEYS
alphai data visualization · based on TradingView
Decision brief

The 30-second read

$WEYSBearishMed
01

Why it matters

The tariff-driven margin compression has led to earnings and sales declines, with some brands like Florsheim showing resilience, possibly indicating brand strength or effective management.

02

Market read

The news is relevant for traders focusing on retail footwear stocks, especially those with exposure to tariffs and demand fluctuations.

03

What to watch

Potential upcoming product launches or strategic initiatives not covered in the news could offset negative impacts.

Timing: Immediate to short-term

Background

Weyco Group's recent earnings report highlights challenges from tariffs and demand softness, affecting margins and sales.

Company-level read

Ticker impact

$WEYSBearishMedium confidence
Context

The news directly pertains to Weyco Group's financial performance, affecting its stock valuation.

Expected impact

Moderate decline in WEYS stock price over the short term, with potential stabilization if Florsheim's outperformance continues.

Evidence & confidence

The earnings decline and tariff pressures are negative factors; however, Florsheim's resilience indicates some company-specific strength, moderating the overall negative outlook.

Market effects

The retail footwear sector may face continued margin pressures and demand challenges, especially for companies exposed to tariffs.

Potential negative impact on US-based footwear retailers; limited impact on international markets.

Low; the impact is primarily regional and sector-specific.

Counterpoint

The company might demonstrate operational resilience, and Florsheim's outperformance could signal a potential turnaround or sector rotation.

Key entities

  • Weyco Group

    A footwear manufacturer and retailer.

  • Florsheim

    A premium footwear brand under Weyco Group.

Related articles

$WEYSMed

Weyco Group (WEYS) Q2 2026 Earnings Call Transcript

Weyco Group (WEYS) reported Q2 2026 net sales of $62.2 million, up 7%, and net earnings of $13.3 million. Diluted EPS was $1.39 versus $0.24 a year earlier, helped by $15.3 million tariff refunds recognized after the U.S. Supreme Court invalidated certain tariffs. Wholesale net sales rose 7% to $48.8 million; cash was $98.1 million with no debt.

$WEYSMed

Weyco Group, Inc. Q2 2026 Earnings Call Summary

Weyco Group, Inc. reported Q2 2026 results boosted by $15.3 million in tariff refunds after a U.S. Supreme Court ruling invalidated prior IEEPA levies, plus 7% wholesale growth led by Florsheim. Management plans to raise inventory to about $70 million by year-end amid tariff uncertainty, including incremental tariffs of 12.5% on imports from China, Dominican Republic and Vietnam.

$WEYSMed

WEYCO GROUP INC (WEYS): Results of Operations and Financial Condition

WEYCO GROUP INC (WEYS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 WEYCO REPORTS SECOND QUARTER 2026 RESULTS ​ ​ Milwaukee, Wisconsin---August 4, 2026---Weyco Group, Inc. (NASDAQ: WEYS) (“we,” “our,” “us” and the “Company”) today announced financial results for the quarter ended June 30, 2026. ​ Second Quarter 2026 Overview ● Net sa

$MSFTHigh

Prediction: Microsoft Could Be the Next $5 Trillion Stock

Microsoft (MSFT) received a BUY rating and $600 price target from 24/7 Wall St., citing 43% Azure growth and a $678B commercial RPO backlog. The stock is up 27.81% over the past month and 3.29% year-to-date, with Q4 FY26 revenue of $90.01B and non-GAAP EPS of $4.74. The target implies 18.9% upside, potentially pushing market cap to $5T. Bulls highlight demand outpacing supply, while bears note capital intensity and declining PC revenue.

$LLYMedAI 9/10

FRI AM News: WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company; State joins lawsuit targeting Trump administration over family planning funding

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi